Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome.

MLA

Lattuca, Benoit, et al. “Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome.” JACC. Cardiovascular Interventions, vol. 17, no. 3, Feb. 2024, pp. 359–70. EBSCOhost, https://doi.org/10.1016/j.jcin.2023.12.011.

APA

Lattuca, B., Mazeau, C., Cayla, G., Ducrocq, G., Guedeney, P., Laredo, M., Dumaine, R., El Kasty, M., Kala, P., Nejjari, M., Hlinomaz, O., Morel, O., Varenne, O., Leclercq, F., Payot, L., Spaulding, C., Beygui, F., Rangé, G., Motovska, Z., … Silvain, J. (2024). Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome. JACC. Cardiovascular Interventions, 17(3), 359–370. https://doi.org/10.1016/j.jcin.2023.12.011

Chicago

Lattuca, Benoit, Cedric Mazeau, Guillaume Cayla, Grégory Ducrocq, Paul Guedeney, Mikael Laredo, Raphaëlle Dumaine, et al. 2024. “Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome.” JACC. Cardiovascular Interventions 17 (3): 359–70. doi:10.1016/j.jcin.2023.12.011.